These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34067302)

  • 1. Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.
    Andras I; Cata ED; Serban A; Kadula P; Telecan T; Buzoianu M; Bungardean M; Stanca DV; Coman I; Crisan N
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34067302
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.
    Yu A; Yamany T; Mojtahed A; Hanna N; Nicaise E; Harisinghani M; Wu CL; Dahl DM; Wszolek M; Blute ML; Feldman AS
    Urol Oncol; 2022 Feb; 40(2):59.e1-59.e5. PubMed ID: 34544650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.
    Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR
    Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer.
    Kayano PP; Carneiro A; Castilho TML; Sivaraman A; Claros OR; Baroni RH; Garcia RG; Mariotti GC; Smaletz O; Filippi RZ; Lemos GC
    Int Braz J Urol; 2018; 44(6):1106-1113. PubMed ID: 30325600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
    Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
    Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy.
    Diamand R; Oderda M; Al Hajj Obeid W; Albisinni S; Van Velthoven R; Fasolis G; Simone G; Ferriero M; Roche JB; Piechaud T; Pastore A; Carbone A; Fiard G; Descotes JL; Marra G; Gontero P; Altobelli E; Papalia R; Kumar P; Eldred-Evans D; Giacobbe A; Muto G; Lacetera V; Beatrici V; Roumeguere T; Peltier A
    World J Urol; 2019 Oct; 37(10):2109-2117. PubMed ID: 30652213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis.
    Özkan A; Köseoğlu E; Kılıç M; Baydar DE; Sağlıcan Y; Balbay MD; Canda AE; Kordan Y; Kiremit MC; Çil B; Tuğcu V; Bakır B; Esen T
    Clin Genitourin Cancer; 2022 Feb; 20(1):e61-e67. PubMed ID: 34750082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
    Mazzone E; Stabile A; Sorce G; Pellegrino F; Barletta F; Motterle G; Scuderi S; Cirulli GO; Cucchiara V; Brembilla G; Esposito A; Gandaglia G; Fossati N; De Cobelli F; Montorsi F; Karnes RJ; Guccini I; Briganti A
    Urol Oncol; 2021 Nov; 39(11):784.e1-784.e9. PubMed ID: 33865687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate magnetic resonance imaging-targeted biopsy global grade correlates better than highest grade with prostatectomy grade.
    Ren J; Melamed J; Taneja SS; Wysock JS; Huang WC; Lepor H; Deng FM
    Prostate; 2023 Mar; 83(4):323-330. PubMed ID: 36461793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?
    Calio BP; Sidana A; Sugano D; Gaur S; Maruf M; Jain AL; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    J Urol; 2018 Apr; 199(4):976-982. PubMed ID: 29154904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
    BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study.
    Diamand R; Hollans M; Lefebvre Y; Sirtaine N; Limani K; Hawaux E; Abou Zahr R; Mattlet A; Albisinni S; Roumeguère T; Peltier A
    Urol Oncol; 2022 May; 40(5):192.e11-192.e17. PubMed ID: 35236622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection with magnetic resonance imaging (MRI)/ cognitive fusion biopsy: Comparing standard and targeted prostate biopsy with final prostatectomy histology.
    Ryan J; Broe MP; Moran D; Mulvin D; Heffernan E; Swan N; Moran DE
    Can Urol Assoc J; 2021 Sep; 15(9):E483-E487. PubMed ID: 33591900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
    Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
    Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.
    Aslan G; Çelik S; Sözen S; Akdoğan B; İzol V; Yücel Bilen C; Sahin B; Türkeri L;
    Int J Clin Pract; 2021 Mar; 75(3):e13797. PubMed ID: 33113261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
    Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
    J Urol; 2019 Dec; 202(6):1182-1187. PubMed ID: 31246548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
    Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L
    Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.